Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis
Chandler E. Jackson(University of Glasgow), Mattie Lenzen, Mark T. Kearney(University of Leeds), Nikki Earle(University of Auckland), John J.V. McMurray(University of Glasgow), Davide Castagno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Mark Richards(National University Health System), Lars Køber(University of Copenhagen), Marco Gorini, José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares), Lilián Grigorian-Shamagian, Marco Guazzi(Ospedale San Paolo), Robert N. Doughty(National Heart Foundation of New Zealand), Colin Berry(University of Glasgow), J. Somaratne(Auckland City Hospital), Richard M. Cubbon(Broad Institute), Bert Andersson(Sahlgrenska University Hospital), Karl Swedberg(Brigham and Women's Hospital), Aldo P. Maggioni(Health Care Foundation), Martín Cowie(National Institutes of Health), Katrina Poppe(University of Auckland), Meta-Analysis Global Group in Chronic Heart, Ali Ahmed(Linköping University), Michel Komajda(Apple (Israel)), S J Pocock(London School of Hygiene & Tropical Medicine), C. B. Granger, B.M. Massie, C. Tribouilloy(Centre Hospitalier Universitaire Amiens-Picardie), Joanna Dobson(University of London), Cono Ariti(University of London), Andrea Di Lenarda(University of Trieste), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol)
Cited by 60
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k